ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "AIEOP-BFM ALL 2009"
AIEOP-BFM ALL 2009
Publikace
Předměty
Osoby
Publikace
Studium
Exportovat aktuální pohled
publication
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009
2023 |
2. lékařská fakulta
publication
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 |
2. lékařská fakulta
publication
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial
2018 |
Publikace bez příslušnosti k fakultě
publication
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
2023 |
2. lékařská fakulta
publication
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
2019 |
2. lékařská fakulta
publication
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
2023 |
2. lékařská fakulta
publication
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol
2023 |
2. lékařská fakulta
publication
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data
2021 |
2. lékařská fakulta
publication
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
2022 |
Publikace bez příslušnosti k fakultě
publication
CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
2024 |
2. lékařská fakulta